Clinical and scientific aspects related to biosimilars in inflammatory bowel diseases (IBD) : position document of the Belgian IBD Research & Development Group (BIRD)
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:78 |
|---|---|
| Enthalten in: |
Acta gastro-enterologica Belgica - 78(2015), 1 vom: 01. Jan., Seite 26-9 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Vermeire, S [VerfasserIn] |
|---|
| Anmerkungen: |
Date Completed 13.01.2017 Date Revised 13.01.2017 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM250380536 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM250380536 | ||
| 003 | DE-627 | ||
| 005 | 20231224155616.0 | ||
| 007 | tu | ||
| 008 | 231224s2015 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n0834.xml |
| 035 | |a (DE-627)NLM250380536 | ||
| 035 | |a (NLM)26118575 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Vermeire, S |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical and scientific aspects related to biosimilars in inflammatory bowel diseases (IBD) |b position document of the Belgian IBD Research & Development Group (BIRD) |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 13.01.2017 | ||
| 500 | |a Date Revised 13.01.2017 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Antibodies, Monoclonal |2 NLM | |
| 650 | 7 | |a Antirheumatic Agents |2 NLM | |
| 650 | 7 | |a Biosimilar Pharmaceuticals |2 NLM | |
| 650 | 7 | |a Gastrointestinal Agents |2 NLM | |
| 650 | 7 | |a Tumor Necrosis Factor-alpha |2 NLM | |
| 650 | 7 | |a golimumab |2 NLM | |
| 650 | 7 | |a 91X1KLU43E |2 NLM | |
| 650 | 7 | |a Infliximab |2 NLM | |
| 650 | 7 | |a B72HH48FLU |2 NLM | |
| 650 | 7 | |a Adalimumab |2 NLM | |
| 650 | 7 | |a FYS6T7F842 |2 NLM | |
| 700 | 1 | |a Louis, E |e verfasserin |4 aut | |
| 700 | 1 | |a Dewit, O |e verfasserin |4 aut | |
| 700 | 1 | |a Franchimont, D |e verfasserin |4 aut | |
| 700 | 1 | |a Moreels, T |e verfasserin |4 aut | |
| 700 | 1 | |a Ferrante, M |e verfasserin |4 aut | |
| 700 | 1 | |a Rahier, J-F |e verfasserin |4 aut | |
| 700 | 1 | |a Van Hootegem, Ph |e verfasserin |4 aut | |
| 700 | 1 | |a De Vos, M |e verfasserin |4 aut | |
| 700 | 1 | |a Mana, F |e verfasserin |4 aut | |
| 700 | 1 | |a Baert, F |e verfasserin |4 aut | |
| 700 | 0 | |a Belgian IBD Research & Development (BIRD) |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Acta gastro-enterologica Belgica |d 1946 |g 78(2015), 1 vom: 01. Jan., Seite 26-9 |w (DE-627)NLM000123749 |x 1784-3227 |7 nnns |
| 773 | 1 | 8 | |g volume:78 |g year:2015 |g number:1 |g day:01 |g month:01 |g pages:26-9 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 78 |j 2015 |e 1 |b 01 |c 01 |h 26-9 | ||